Quotient (QTNT) Reports Q3 Loss of $0.48
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Quotient Limited Reports Third Quarter Fiscal 2016 Financial Results
February 8, 2016 7:45 AM ESTConsiderable progress on development and commercial scale-up of MosaiQ, Quotients next-generation automation platform for transfusion diagnosticsMarketing of MosaiQ expected to start in the fourth quarter of 2016 in Europe with U.S. commercial launch anticipated in the first quarter of 2018, if licensed for saleProduct sales of $4.4 million in 3QFY16, exceeding guidanceIn January, announced MosaiQ platform will be expanded to include Nucleic Acid Testing (or NAT)Priced an underwritten public offering of 4.4 million ordinary shares expected to raise net proceeds of $36.9... More
